BDRFY:OTO-Beiersdorf AG ADR (USD)

COMMON STOCK | Household & Personal Products | OTC Pink

Last Closing

USD 31.7

Change

0.00 (0.00)%

Market Cap

USD 20.80B

Volume

9.44K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Beiersdorf AG along with its subsidiaries is engaged in the manufacture and distribution of branded consumer goods in the area of skin and body care, and of the manufacture and distribution of technical adhesive tapes.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-26 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
LRLCF L'Oréal S.A

N/A

USD 261.83B
LRLCY L’Oreal Co ADR

N/A

USD 260.86B
UNLYF Unilever PLC

N/A

USD 141.45B
RBGLY Reckitt Benckiser Group PLC AD..

N/A

USD 40.86B
RBGPF Reckitt Benckiser Group PLC

N/A

USD 39.81B
HENOY Henkel Ag A

N/A

USD 37.79B
HELKF Henkel AG & Co. KGaA

N/A

USD 36.17B
HENOF Henkel AG & Co. KGaA

N/A

USD 35.68B
BDRFF Beiersdorf Aktiengesellschaft

N/A

USD 35.37B
HENKY Henkel AG & Co KGAA

N/A

USD 35.32B

ETFs Containing BDRFY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.03% 60% D- 58% F
Dividend Return 0.72% 6% D- 13% F
Total Return 6.75% 60% D- 58% F
Trailing 12 Months  
Capital Gain 19.31% 76% C+ 74% C
Dividend Return 0.81% 11% F 10% F
Total Return 20.12% 75% C 72% C
Trailing 5 Years  
Capital Gain 37.11% 89% A- 77% C+
Dividend Return 4.36% 17% F 14% F
Total Return 41.47% 85% B 74% C
Average Annual (5 Year Horizon)  
Capital Gain 6.27% 51% F 50% F
Dividend Return 7.17% 45% F 47% F
Total Return 0.90% 9% A- 21% F
Risk Return Profile  
Volatility (Standard Deviation) 16.30% 90% A- 91% A-
Risk Adjusted Return 43.96% 93% A 82% B
Market Capitalization 20.80B 90% A- 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.